Sigmatic Sciences will be at the BIO International Convention, June 22–25 in San Diego, showing biotech teams how to actually run frontier AI in their labs, not just talk about it.
The Gap Isn’t the Models. It’s Access.
The most powerful AI in drug discovery exists. NVIDIA’s BioNeMo stack, OpenFold3, Boltz-2, RNApro, ReaSyn, is extraordinary science. But for most biotech organizations, it sits out of reach: too much infrastructure to wrangle, too disconnected from lab workflows, too hard to govern at the speed discovery actually demands.
SigmaticOS is the operating system that closes that gap.
What We’re Bringing to San Diego
We’ve run NVIDIA BioNeMo and Nemotron in production since day one. What we’ve built on top is a coordinated AI Scientist, 300+ specialized agents that can reason, plan, and execute across the full discovery lifecycle, connected to your ELN, LIMS, lab automation, literature, and simulation tools, with your scientists in control at every step.
This isn’t a demo of what AI could do for biotech someday. It’s a live system running the models you’ve been watching from the sidelines, traceable, governed, and integrated with the lab itself.
What That Means for Your Team
Biotech companies shouldn’t need hyperscaler infrastructure budgets or a team of ML engineers to put frontier AI to work. SigmaticOS makes NVIDIA’s capabilities accessible, operational, and scientifically accountable, so your discovery teams can move faster without flying blind.
See It Live in San Diego
If your organization has been watching agentic AI from a distance, this is where you come in from the sidelines.
| Sigmatic Sciences will showcase its BioNeMo-powered AI Scientist workflows at the BIO International Convention, June 22–25 in San Diego. |
